Latest Insider Transactions at Neurocrine Biosciences Inc (NBIX)
This section provides a real-time view of insider transactions for Neurocrine Biosciences Inc (NBIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEUROCRINE BIOSCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEUROCRINE BIOSCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Eiry Roberts Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,345
+5.52%
|
$624,325
$85.2 P/Share
|
|
Nov 04
2024
|
Stephen A Sherwin Director |
SELL
Bona fide gift
|
Direct |
2,000
-7.55%
|
-
|
|
Oct 03
2024
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,295
-77.45%
|
$146,335
$113.66 P/Share
|
|
Sep 13
2024
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
3,461
-67.43%
|
$418,781
$121.88 P/Share
|
|
Aug 15
2024
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
14,250
-27.54%
|
$2,080,500
$146.69 P/Share
|
|
Aug 13
2024
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
11,570
-8.86%
|
$1,735,500
$150.43 P/Share
|
|
Aug 13
2024
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,570
+8.14%
|
$485,940
$42.76 P/Share
|
|
Aug 13
2024
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,100
-30.9%
|
$2,115,000
$150.38 P/Share
|
|
Aug 13
2024
|
Matt Abernethy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,100
+23.61%
|
$1,029,300
$73.6 P/Share
|
|
Aug 13
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
7,143
-46.79%
|
$1,071,450
$150.11 P/Share
|
|
Aug 13
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,043
+23.97%
|
$313,429
$103.52 P/Share
|
|
Aug 06
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
273
-3.97%
|
$40,131
$147.7 P/Share
|
|
Aug 06
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+3.82%
|
$21,567
$79.02 P/Share
|
|
Aug 01
2024
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,632
-40.97%
|
$1,932,696
$153.26 P/Share
|
|
Aug 01
2024
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,632
+29.06%
|
$770,552
$61.82 P/Share
|
|
Aug 01
2024
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,996
-7.01%
|
$461,384
$154.01 P/Share
|
|
Aug 01
2024
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,996
+6.55%
|
$236,684
$79.02 P/Share
|
|
Jul 16
2024
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
900
-4.71%
|
$135,000
$150.04 P/Share
|
|
Jul 16
2024
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+4.5%
|
$54,900
$61.82 P/Share
|
|
Jul 16
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
2,857
-11.41%
|
$428,550
$150.05 P/Share
|
|
Jul 16
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,957
+9.74%
|
$201,571
$103.52 P/Share
|
|
Jul 16
2024
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
930
-0.78%
|
$139,500
$150.03 P/Share
|
|
Jul 16
2024
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
930
+0.77%
|
$39,060
$42.76 P/Share
|
|
Jul 16
2024
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
900
-2.78%
|
$135,000
$150.04 P/Share
|
|
Jul 16
2024
|
Matt Abernethy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+2.7%
|
$65,700
$73.6 P/Share
|
|
Jul 16
2024
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,004
-14.98%
|
$1,050,600
$150.0 P/Share
|
|
Jul 16
2024
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,004
+13.03%
|
$553,316
$79.02 P/Share
|
|
Jul 01
2024
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
10,000
-35.46%
|
$1,400,000
$140.19 P/Share
|
|
Jul 01
2024
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+26.18%
|
$610,000
$61.82 P/Share
|
|
Jul 01
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
272
-3.5%
|
$37,536
$138.11 P/Share
|
|
Jul 01
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
272
+3.38%
|
$21,488
$79.02 P/Share
|
|
May 31
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
273
-3.51%
|
$37,128
$136.55 P/Share
|
|
May 31
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+3.39%
|
$21,567
$79.02 P/Share
|
|
May 29
2024
|
Stephen A Sherwin Director |
SELL
Open market or private sale
|
Direct |
40,000
-42.34%
|
$5,320,000
$133.47 P/Share
|
|
May 29
2024
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+29.61%
|
$1,800,000
$45.32 P/Share
|
|
May 17
2024
|
Shalini Sharp Director |
SELL
Open market or private sale
|
Direct |
1,106
-52.67%
|
$155,946
$141.9 P/Share
|
|
May 17
2024
|
Shalini Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+50.0%
|
-
|
|
May 17
2024
|
Richard F Pops Director |
SELL
Open market or private sale
|
Direct |
2,100
-6.23%
|
$296,100
$141.84 P/Share
|
|
May 17
2024
|
Richard F Pops Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,199
+11.08%
|
-
|
|
May 17
2024
|
George J Morrow Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,199
+50.0%
|
-
|
|
May 17
2024
|
Leslie V Norwalk Director |
SELL
Open market or private sale
|
Direct |
1,106
-52.67%
|
$155,946
$141.82 P/Share
|
|
May 17
2024
|
Leslie V Norwalk Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+50.0%
|
-
|
|
May 17
2024
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+1.73%
|
-
|
|
May 17
2024
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,199
+13.68%
|
-
|
|
May 17
2024
|
Johanna Mercier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+50.0%
|
-
|
|
May 15
2024
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-32.24%
|
$2,100,000
$140.24 P/Share
|
|
May 15
2024
|
Matt Abernethy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+24.38%
|
$1,095,000
$73.6 P/Share
|
|
May 14
2024
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
12,500
-9.66%
|
$1,687,500
$135.63 P/Share
|
|
May 14
2024
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+8.81%
|
$525,000
$42.76 P/Share
|
|
May 14
2024
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-32.24%
|
$2,025,000
$135.66 P/Share
|